Skip to content

Avantor AVTR Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

Agilent Technologies logo
Agilent TechnologiesA
$1M0.0%
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
$5.5M+120%
DuPont de Nemours, Inc. logo
DuPont de Nemours, Inc.DD
$84M+2,000%
Entegris logo
EntegrisENTG
$14.3M+921%
Revvity logo
RevvityRVTY
$5.44M+107%
Veralto logo
VeraltoVLTO
$0-100%

Other financials

Income statement

See full
Revenue$1.6B0.0%
Gross profit$500.7M-6.4%
Operating income$99.5M-32.5%
Net income$43.3M-32.9%
EPS (diluted)$0.06-33.3%

Balance sheet

See full
Cash & equivalents$282.2M-11.4%
Total debt$3.8B-7.1%
Total equity$5.6B-8.4%
Total assets$11.7B-5.4%

Cash flow

See full
Operating cash flow$58.7M-46.3%
CapEx$33.5M+19.6%
Free cash flow$25.2M-69.0%

Valuation

See full
Market cap$6.54B-52.0%
Enterprise value$10.07B-40.4%
P/S-1.0×

Profitability

See full
Gross margin32.1%-1.4pp
Operating margin4%-5.2pp
Net margin-9.2%-19.9pp
FCF margin6.7%-3.3pp

Returns & leverage

See full
Return on equity-10.3%-22.8pp
Debt / equity0.7×0.0×
Current ratio1.8×+0.6×

Where this comes from

Reported directly by Avantor in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromStockOptionsExercised.

The official record: Avantor’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avantor's stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Avantor's stock issuance proceeds?
Avantor (AVTR) reported stock issuance proceeds of $1.9M in Q1 2026.
How has Avantor's stock issuance proceeds changed year-over-year?
Avantor's stock issuance proceeds decreased by 26.9% year-over-year, from $2.6M to $1.9M.
What is the long-term trend for Avantor's stock issuance proceeds?
Over 4 years (2021 to 2025), Avantor's stock issuance proceeds has grown at a -73.1% compound annual growth rate (CAGR), from $967M to $5.1M.
What does stock issuance proceeds mean?
Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.